These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 604150)

  • 1. [First results with a new prostaglandin E2-derivate (author's transl)].
    Schmidt-Gollwitzer M; Schmidt-Gollwitzer K; Schüssler B; Koch R; Nevinny-Stickel J
    Geburtshilfe Frauenheilkd; 1977 Dec; 37(12):1030-8. PubMed ID: 604150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
    Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCG, progesterone and 17-beta-estradiol levels during extra-amniotically induced early abortion by a new prostaglandin derivative (Sulprostone).
    Nilsson S; Zador G; Nygren KG; Wide L
    Gynecol Obstet Invest; 1981; 12(4):203-10. PubMed ID: 7250783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction of abortion during the second and third trimester of pregnancy with sulprostone (author's transl)].
    Heinzl S; Winkler C
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):231-6. PubMed ID: 7215768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
    Schmidt-Gollwitzer K; Hoebich D; Hardt W; Schuessler B; Schmidt-Gollwitzer M
    Int J Fertil; 1981; 26(2):86-93. PubMed ID: 6114070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Extraamniotic induction of abortion with a new prostaglandin E-2 derivative].
    Gethmann U; Schuster E; Hoppen HO; Oberheuser F
    Fortschr Med; 1978 Sep; 96(35):1771-3. PubMed ID: 738690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Combined pericervical and intramuscular administration of prostaglandin for the termination of pregnancy in the 2d and 3d trimester].
    Grünberger W; Husslein P
    Geburtshilfe Frauenheilkd; 1983 Apr; 43(4):240-4. PubMed ID: 6553545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sulprostone, a new prostaglandin E2 derivative (author's transl)].
    Schüssler B; Schmidt-Gollwitzer K; Schmidt-Gollwitzer M
    Dtsch Med Wochenschr; 1979 Nov; 104(48):1697-701. PubMed ID: 520164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with sulprostone (author's transl)].
    Brabec W; Dapunt O; Bichler A
    Wien Klin Wochenschr; 1981 Mar; 93(6):193-7. PubMed ID: 7281695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plasma hormone concentrations in induced abortion with local prostaglandin administration in the 1st trimester].
    Rath W; König A; Ulbrich R; Hilgers R; Kuske R; Kuhn W
    Zentralbl Gynakol; 1983; 105(15):961-71. PubMed ID: 6578640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine prostaglandin E2 as an postconceptional abortifacient.
    Mackenzie IZ; Hillier K; Embrey MP
    Adv Prostaglandin Thromboxane Res; 1976; 2():687-91. PubMed ID: 983869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outpatient termination of pregnancy via intramural single-shot application of the prostaglandin derivative sh b 286 (sulproston) (author's transl)].
    Wiechell H
    Geburtshilfe Frauenheilkd; 1979 May; 39(5):401-3. PubMed ID: 456862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Termination of pregnancy and evacuation of the uterine contents in the second trimester. Use of a prostaglandin E2 analog: sulprostone].
    Barrat J; Cabrol D; Chouraqui A; Crépin G; Dumez Y; Hacker R; Henrion R; Magnin G; Soutoul JH; Sureau C
    J Gynecol Obstet Biol Reprod (Paris); 1987; 16(1):93-9. PubMed ID: 3584870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone levels during prostaglandin F 2 infusions for therapeutic abortion.
    Speroff L; Caldwell BV; Brock WA; Anderson GG; Hobbins JC
    J Clin Endocrinol Metab; 1972 Mar; 34(3):531-6. PubMed ID: 5011257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical trials of intramuscular sulprostone for second trimester abortion.
    Intaraprasert S; Sugkraroek P
    J Med Assoc Thai; 1988 Mar; 71 Suppl 1():58-62. PubMed ID: 3047304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of determinations of human chorionic gonatrophin, human placental lactogen, progesterone and oestriol in women with threatened abortion (author's transl)].
    Gerhard I; Runnebaum B
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):785-99. PubMed ID: 700341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Termination of pregnancy during the IInd and IIIrd trimester with Sulproston (SH B 286 AD) (author's transl)].
    Cornely M
    Med Klin; 1978 Sep; 73(37):1281-7. PubMed ID: 567740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dose-dependent effect of locally administered sulprostone gel on serum luteal and placental hormones in cervix priming in the 1st trimester].
    Rath W; Pitzel L; Hilgers R; Kuhn W
    Zentralbl Gynakol; 1989; 111(10):634-44. PubMed ID: 2750356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [16-Phenoxy-prostaglandin-E2 for inducing abortion in intact and complicated pregnancy].
    Lichtenegger W
    Geburtshilfe Frauenheilkd; 1984 Nov; 44(11):752-7. PubMed ID: 6569011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.